Patents, Legal Monopolies, and the High Prices for Drugs

Tags: Prices, Bureaucracy and Regulation, Price Controls

03/22/2022 Benjamin Williams

While government officials and politicians denounce high drug prices, they have created monopoly privileges for drug firms, thus ensuring higher-than-competitive prices for pharmaceuticals.

Original Article: “Patents, Legal Monopolies, and the High Prices for Drugs“

This Audio Mises Wire is generously sponsored by Christopher Condon. Narrated by Michael Stack.

The Mises Institute is a non-profit organization that exists to promote teaching and research in the Austrian School of economics, individual freedom, honest history, and international peace, in the tradition of Ludwig von Mises and Murray N. Rothbard.

Non-political, non-partisan, and non-PC, we advocate a radical shift in the intellectual climate, away from statism and toward a private property order. We believe that our foundational ideas are of permanent value, and oppose all efforts at compromise, sellout, and amalgamation of these ideas with fashionable political, cultural, and social doctrines inimical to their spirit.